Associated Papers
Multi-omics study identifies diagnostic metabolic signatures of early Parkinson's disease associated with dysregulated glutathione and TCA cycle metabolism.
Wang N et al.
Parkinsonism & Related Disorders, 2026
Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease.
Elshaikh RH et al.
Medicina (kaunas, Lithuania), 2026
Serum Calcium Concentration Is Associated with Bone Mineral Density and Synonymous Variants in the RYR1 Gene in a Mexican-Mestizo Population.
López-Pérez TV et al.
Medical Sciences (basel, Switzerland), 2025
The Effect of ABCB1 Polymorphisms on the Efficacy of Antidepressants.
Thorsen SV et al.
Basic & Clinical Pharmacology & Toxicology, 2025
The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals.
Singam H et al.
Genes, 2025
Modeling the Influence of CYP2C9 and ABCB1 Gene Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Losartan.
Babaev D et al.
Pharmaceutics, 2025
Multidrug resistance Gene-1 polymorphisms (C3435T and G2677T) and the risk of inflammatory bowel disease in Egyptian patients.
Marzaban R et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-arab Association of Gastroenterology, 2025
Influence of Multidrug Resistance 1 Gene Variants on Response to Intravenous Methylprednisolone Pulse in Systemic Lupus Erythematosus Patients: Preliminary Results.
Attia DHS et al.
Current Rheumatology Reviews, 2025
The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation.
Duan Z et al.
British Journal of Haematology, 2024
A descriptive study of the single-nucleotide polymorphisms known to affect the Tacrolimus trough concentration per dose, among a population of kidney failure patients in a tertiary hospital in Ghana.
Kwakyi E et al.
Bmc Research Notes, 2024
Effect of MDR1 C3435T and CYP2C19 genetic polymorphisms on the outcome of Helicobacter pylori eradication treatment in children with gastritis and peptic ulcer, Vietnam.
Thuy LLT et al.
Bmc Pediatrics, 2024
Association between the MDR1 rs1045642 polymorphism and breast cancer risk: An updated meta‑analysis.
Gong L et al.
Oncology Letters, 2024
Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis.
Liu B et al.
World Journal of Surgical Oncology, 2024
Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review.
Zheng Y et al.
Frontiers in Pharmacology, 2024
Genetic polymorphisms in ABCB1 are correlated with the increased risk of atorvastatin-induced muscle side effects: a cross-sectional study.
Lalatović N et al.
Scientific Reports, 2023
GPX3 rs8177412 Polymorphism Modifies Risk of Upper Urothelial Tumors in Patients with Balkan Endemic Nephropathy.
Radic Savic Z et al.
Medicina (kaunas, Lithuania), 2023
Candidate Genes for Prediction of Efficacy and Safety of Statin Therapy in the Kazakh Population.
Tuleutayeva RY et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies, 2023
Influence of polymorphisms in CYP2C9, VKORC1, MDR1 and APOE genes on the warfarin maintenance dose in Brazilian patients.
de Freitas Campos EI et al.
Pharmacogenomics, 2023
Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy.
Shyamveer et al.
The Journal of Gene Medicine, 2023
An Improved Technique for Genotyping the ABCB1 Gene Variant of Exon 21.
Zuccoli JR et al.
Methods and Protocols, 2023
Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.
Korkor MS et al.
Italian Journal of Pediatrics, 2023
The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy.
Radosavljevic M et al.
Genes, 2023
Effects of MDR1 and OPRM1 genetic polymorphisms on the pharmacodynamics of propofol-remifentanil TIVA in pediatrics.
Liew Y et al.
Pharmacogenomics, 2023
The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis.
Teng Y et al.
Journal of Personalized Medicine, 2023
The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern-West, Iran.
Jabbari Hagh E et al.
Advanced Pharmaceutical Bulletin, 2023
Impact of single-nucleotide polymorphisms on tacrolimus pharmacokinetics in liver transplant patients after switching to once-daily dosing.
Park J et al.
Hepatology International, 2023
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA et al.
Pharmacogenetics and Genomics, 2022
A meta-analysis and experimental data for multidrug resistance genes in breast cancer.
Zaib S et al.
African Health Sciences, 2022
Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction.
Gandhi M et al.
Translational Oncology, 2022
The Pharmacogenetics of Cannabis in the Treatment of Chronic Pain.
Poli P et al.
Genes, 2022
Influence of MDR1 gene polymorphism (2677G>T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation.
Yamasaki Y et al.
Pharmacogenetics and Genomics, 2022
Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults.
Matheson J et al.
Brain Sciences, 2022
Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes.
Šimičević L et al.
Journal of Clinical Pharmacy and Therapeutics, 2022
Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia.
Shriyan B et al.
European Journal of Clinical Pharmacology, 2022
Genetic variation at the catalytic subunit of glutamate cysteine ligase contributes to the susceptibility to sporadic colorectal cancer: a pilot study.
Bykanova MA et al.
Molecular Biology Reports, 2022
Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane.
Sun Z et al.
The Journal of Gene Medicine, 2022
Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.
Hegazi HM et al.
Leukemia Research, 2022
Association of Specific Genetic Polymorphisms with Atraumatic Osteonecrosis of the Femoral Head: A Narrative Review.
Kumar P et al.
Indian Journal of Orthopaedics, 2022
Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study.
Melikoglu MA et al.
Inflammopharmacology, 2022
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: A meta-analysis.
Louati N et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 2022
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.
Biswas M et al.
Frontiers in Pharmacology, 2022
Editorial: Advances in genomic and genetic tools, and their applications for understanding embryonic development and human diseases.
Abu-Elmagd M et al.
Frontiers in Cell and Developmental Biology, 2022
Synonymous mutations in the phosphoglycerate kinase 1 gene induce an altered response to protein misfolding in Schizosaccharomyces pombe.
Moreira-Ramos S et al.
Frontiers in Microbiology, 2022
Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma-A retrospective cohort study.
Gong Y et al.
Journal of Clinical Pharmacy and Therapeutics, 2021
Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia.
Sivkov A et al.
Lipids in Health and Disease, 2021
Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach.
Parvin MN et al.
Journal of Advanced Research, 2021
Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
Fan YX et al.
Epilepsy Research, 2021
Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistant phenotype in childhood idiopathic nephrotic syndrome.
Prasad N et al.
The Pharmacogenomics Journal, 2021
Analysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatment.
Wang S et al.
Clinical and Translational Science, 2021
Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia.
Hindi NN et al.
Journal of Personalized Medicine, 2021